Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection.

MLA

Duwal, Sulav, et al. “Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection.” PloS One, vol. 7, no. 7, 2012, p. e40382. EBSCOhost, https://doi.org/10.1371/journal.pone.0040382.

APA

Duwal, S., Schütte, C., & von Kleist, M. (2012). Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection. PloS One, 7(7), e40382. https://doi.org/10.1371/journal.pone.0040382

Chicago

Duwal, Sulav, Christof Schütte, and Max von Kleist. 2012. “Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection.” PloS One 7 (7): e40382. doi:10.1371/journal.pone.0040382.